In February 2025, Gan & Lee Pharmaceuticals (hereafter referred to as "Gan & Lee," stock code: 603087.SH) unveiled that the first participant was successfully dosed in a large-scale Phase 3 clinical trial (OPTIMUM-2) of Bofanglutide, a bi-weekly glucagon-like peptide-1 receptor agonist (GLP-1RA) independently, in Chinese participant with type 2 diabetes mellitus (T2DM)
The first generation of GLP-1 agonists (e.g
KAT6A occurs in a protein complex with the chromatin adaptor proteins BRPF1, BRPF2, or BRPF3, ING4 or ING5, and MEAF6 (Doyon et al, 2006)
While much has been published on cellular expression of GPCRs, including the GLP-1R, when evaluating the validity of such data it is key to consider the methodologies applied [e.g., immunohistochemistry (IHC), in situ hybridization (ISH), polymerase chain reaction (PCR), in situ ligand binding (ISBL)]
276 In its resting state, STING resides in the ER, where it interacts with the Ca 2+ -sensing transmembrane protein stromal interaction molecule 1 (STIM1) and the ER Ca 2+ pump ATPase sarcoplasmic/endoplasmic reticulum Ca 2+ transporting 2 (ATP2A2, also known as SERCA2)
Your MedBridge Care Team is Here to Help Our interdisciplinary team will work closely with you to ensure you are confident in administering your medication correctly